Nktx stock forecast.
What is Nkarta's Market Cap? ( NASDAQ: NKTX) Nkarta 's market cap is $127.10M, as of Nov 24, 2023. Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares. Nkarta 's market cap is calculated by multiplying NKTX 's current stock price of $2.59 by NKTX 's total outstanding shares of.
6.1%. 10% most volatile stocks in US Market. 15.2%. 10% least volatile stocks in US Market. 2.9%. Stable Share Price: NKTX is more volatile than 90% of US stocks over the past 3 months, typically moving +/- 35% a week. Volatility Over Time: NKTX's weekly volatility has increased from 20% to 35% over the past year.Preliminary cancer treatment data is pushing the stock higher today. Nkarta (NASDAQ: NKTX) stock is rocketing higher on Monday after the company released preliminary data from a Phase 1 clinical ...Of the 101 institutional investors that purchased Nkarta stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Deep Track Capital LP ($2.11M), State Street Corp ($2.05M), Wasatch Advisors LP ($1.98M), Braidwell LP ($1.53M), Price T Rowe Associates Inc. MD ($1.52M), Tang …Dec 1, 2023 · Analyst Forecast According to 6 analysts, the average rating for NKTX stock is "Strong Buy." The 12-month stock price forecast is $13.0, which is an increase of 377.94% from the latest price.
In 2022, GSK plc's revenue was 29.32 billion, an increase of 18.74% compared to the previous year's 24.70 billion. Earnings were 14.96 billion, an increase of 241.07%. Financial numbers in GBP Financial Statements.
We would like to show you a description here but the site won’t allow us. Oct. 18, 2023, 08:00 AM Analysts have provided the following ratings for Nkarta (NASDAQ:NKTX) within the last quarter: In the last 3 months, 7 analysts have offered 12 …
Track Nkarta Inc (NKTX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors Financials. NKTX has a market cap of $164mn and a cash balance of $354mn. Research and development (R&D) expenses were $90.9 million for the full year 2022 and $26.8 million for the fourth quarter ...Find real-time M - Macy's Inc stock quotes, company profile, news and forecasts from CNN Business.The average Barrick Gold stock price prediction forecasts a potential upside of 31.13% from the current GOLD share price of $17.73. What is GOLD's forecast return on equity (ROE) for 2023-2026? (NYSE: GOLD) forecast ROE is N/A, which is considered weak.Find the latest Zymeworks Inc. (ZYME) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid ...
Nkarta (NKTX) is a clinical-stage biopharmaceutical company that develops and commercializes cell therapies for cancer treatment. The company's co-lead product candidates are NKX101 and NKX019, which are in phase I trials for various B cell malignancies. Analysts have a consensus rating of Buy and a price target of $15.67, up 671.8% from its current price of $2.03.
About the Nkarta, Inc. stock forecast. As of 2023 October 17, Tuesday current price of NKTX stock is 1.495$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).
Market cap is calculated by taking a company's price per share and multiplying it by the company's total number of shares outstanding. $68.19M. -89.4%. Market Cap / Employee. The market cap of a ...Since the start of the year, NKTX lost 77% of its equity value. However, in sharp contrast to the market performance, analysts rate NKTX a unanimous strong buy. Their average price target lands at ...The average price target for Macy's is $14.83. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $19.00 ,the lowest forecast is $10.00. The average price target represents -0.07% Decrease from the current price of $14.84.Find real-time M - Macy's Inc stock quotes, company profile, news and forecasts from CNN Business.Chief Financial & Business Officer exercised options and sold US$71k worth of stock Jul 28. Nkarta, Inc. Announces Executive Changes Jul 26. Price target decreased to US$43.56 Jul 18. ... NKTX is forecast to remain unprofitable over the next 3 years. Revenue vs Market: NKTX is forecast to have no revenue next year.Chief Financial & Business Officer exercised options and sold US$71k worth of stock Jul 28. Nkarta, Inc. Announces Executive Changes Jul 26. Price target decreased to US$43.56 Jul 18. ... NKTX is forecast to remain unprofitable over the next 3 years. Revenue vs Market: NKTX is forecast to have no revenue next year.
NKTX Earnings Forecast. Next quarter’s earnings estimate for NKTX is -$0.59 with a range of -$0.96 to -$0.40. The previous quarter’s EPS was -$0.52. NKTX beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 59.59% of the time in the same period.Nov 30, 2023 · Price Target Based on short-term price targets offered by seven analysts, the average price target for Nkarta, Inc. comes to $12.57. The forecasts range from a low of $9.00 to a high of $15.00.... NKTX Stock Price | Nkarta Inc. Stock Quote (U.S.: Nasdaq) | MarketWatch Home Investing Quotes Stocks United States NKTX Overview Stock Screener Earnings Calendar Sectors Nasdaq |...The U.S. National Weather Service (NWS) is a part of the National Oceanic and Atmospheric Administration (NOAA). Many people rely on the National Weather Service’s forecasts in order to better anticipate what the weather will be like so the...Acumen Pharmaceuticals Inc. 2.37. +0.01. +0.42%. Get Nkarta Inc (NKTX:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.Nkarta Stock Forecast, "NKTX" Share Price Prediction Charts Is "Nkarta Inc" a Good Investment? Current price today: 2.675 USD (+0.753%) History Forecast Data Market …NKTX : Nkarta stock forecast by Wall Street Analysts. The average Nkarta stock forecast from last 6 month is $14.5, and this show a -37.64% decrease in average from the prior price target of the each prediction. Also, this average forecast of $14.5 represents a -42.98% decrease from the past average forecast of $25.43, 6 months ago …
Nkarta (NKTX) Stock Forecast & Price Prediction Estimation of the future price movement of Nkarta stock, based on various factors such as historical price trends, market trends, …
The average Barrick Gold stock price prediction forecasts a potential upside of 31.13% from the current GOLD share price of $17.73. What is GOLD's forecast return on ...In December 2022, Nkarta had US$352m in cash, and was debt-free. Looking at the last year, the company burnt through US$104m. So it had a cash runway of about 3.4 years from December 2022. There's ...Find the latest Tritium DCFC Limited (DCFC) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W ...Nov 27, 2023 · According to the issued ratings of 5 analysts in the last year, the consensus rating for Nkarta stock is Buy based on the current 1 hold rating, 3 buy ratings and 1 strong buy rating for NKTX. The average twelve-month price prediction for Nkarta is $14.67 with a high price target of $26.00 and a low price target of $9.00. Stock Price Forecast. According to 5 stock analysts, the average 12-month stock price forecast for Nkarta stock is $13, which predicts an increase of 392.42%. …Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools. Identify stocks that meet your criteria using seven unique stock screeners.According to . 4 Wall Street analysts that have issued a 1 year NKTX price target, the average NKTX price target is $11.75, with the highest NKTX stock price forecast at $15.00 and the lowest NKTX stock price forecast at $9.00.IOBT Stock 12 Months Forecast. $9.00. (837.99% Upside) Based on 3 Wall Street analysts offering 12 month price targets for IO Biotech in the last 3 months. The average price target is $9.00 with a high forecast of $10.00 and a low forecast of $8.00. The average price target represents a 837.99% change from the last price of $0.96.Nkarta, Inc. (NKTX) stock forecast and price target. Find the latest Nkarta, Inc. NKTX analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.
Company Summary. Nkarta Inc. is a biopharmaceutical company. It develops and commercializes cell therapies for cancer treatment. The company's product candidate includes NKX101 and NKX019, which ...
However, the unknown biotech stock holds value at current levels. With some promising developments, NKTX stock is likely to surge in 2023. For clinical-stage biotechnology companies, financing ...
Nkarta Inc Price (NKTX) Daily Price Prediction Charts. Markets; Forecast . Crypto Forecasts; Top 5 Crypto forecasts; Tether Usdt forecast; Carebit forecast; Bitcoin forecast; ... Top 5 LSE Stock Forecasts; Trustpilot (TRST) forecast; Shell (SHEL) forecast; Haleon (HLN) forecast; AstraZeneca (AZN) forecast; Lloyds (LLOY) …Chief Financial & Business Officer exercised options and sold US$71k worth of stock Jul 28. Nkarta, Inc. Announces Executive Changes Jul 26. Price target decreased to US$43.56 Jul 18. ... NKTX is forecast to remain unprofitable over the next 3 years. Revenue vs Market: NKTX is forecast to have no revenue next year.Get the latest Nkarta, Inc. (NKTX) stock news and headlines to help you in your trading and investing decisions.According to the issued ratings of 7 analysts in the last year, the consensus rating for Vor Biopharma stock is Buy based on the current 7 buy ratings for VOR. The average twelve-month price prediction for Vor Biopharma is $15.19 with a high price target of $22.00 and a low price target of $10.00. Learn more on VOR's analyst rating history.Find the latest Zymeworks Inc. (ZYME) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid ...Reed's, Inc. (NYSE:REED) posted its quarterly earnings data on Thursday, November, 9th. The company reported ($0.34) earnings per share for the quarter, topping the consensus estimate of ($0.40) by $0.06. The business had revenue of $11.86 million for the quarter, compared to analysts' expectations of $15.38 million.Nkarta has generated ($2.50) earnings per share over the last year ( ($2.50) diluted earnings per share). Earnings for Nkarta are expected to grow in the coming year, from ($2.50) to ($2.42) per share. Nkarta has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 21st, 2024 ...The 12-month stock price forecast is $20.25, which is an increase of 208.69% from the latest price. Price Target. $20.25 (208.69% upside) Analyst Consensus: Strong Buy. Stock Forecasts. News. All; Videos; Press Press Releases; Conversation; ... Other symbols: AFMD BCAB EIGR GRCL NKTX TIL. 11 months ago - Barrons.Analysts have provided the following ratings for Nkarta (NASDAQ:NKTX) within the last quarter: In the last 3 months, 7 analysts have offered 12-month price targets for Nkarta. The company has an ...The average Pinterest stock price prediction forecasts a potential upside of 1.4% from the current PINS share price of $34.07. What is PINS's forecast return on equity (ROE) for 2023-2026? (NYSE: PINS) forecast ROE is N/A, which is considered weak.RBC Capital analyst Tyler Broda downgraded the stock from Outperform to Sector Perform. Sibanye Stillwater shares fell 2.3% to $6.01 in pre-market trading. See how other analysts view this stock .
Stock Price Forecast. The 10 analysts offering 12-month price forecasts for Fisker Inc have a median target of 4.50, with a high estimate of 11.00 and a low estimate of 2.00. The median estimate ...Find the latest Elastic N.V. (ESTC) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid Term ...Nkarta, Inc. Stock Earnings. The value each NKTX share was expected to gain vs. the value that each NKTX share actually gained. Nkarta, Inc. ( NKTX) reported Q3 2023 earnings per share (EPS) of -$0.52, beating estimates of -$0.67 by 22.07%. In the same quarter last year, Nkarta, Inc. 's earnings per share (EPS) was -$0.58.Nkarta, Inc. (NKTX) stock forecast and price target. Find the latest Nkarta, Inc. NKTX analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.Instagram:https://instagram. berry global group increit hotelsdelta pilot salariesautozomne According to the issued ratings of 7 analysts in the last year, the consensus rating for Nektar Therapeutics stock is Reduce based on the current 2 sell ratings, 4 hold ratings and 1 buy rating for NKTR. The average twelve-month price prediction for Nektar Therapeutics is $3.00 with a high price target of $6.00 and a low price target of $1.00. b and g foods incipo cart RBC Capital analyst Tyler Broda downgraded the stock from Outperform to Sector Perform. Sibanye Stillwater shares fell 2.3% to $6.01 in pre-market trading. See how other analysts view this stock .Preliminary cancer treatment data is pushing the stock higher today. Nkarta (NASDAQ: NKTX) stock is rocketing higher on Monday after the company released preliminary data from a Phase 1 clinical ... forex exchange demo Volume 525.26K. Average Volume (3M) 2.57M. Market Cap. $128.32M. Enterprise Value -$61.93M. Total Cash (Recent Filing) $280.75M. Total Debt (Recent Filing) $90.50M. Price to Earnings (P/E) -1.0. Beta 0.73.At the time of writing, Nkarta Inc [NKTX] stock is trading at $1.57, up 13.77%. In order to assess the stock's recent performance, you can check whether its short-term value is rising or falling. The NKTX shares have gain 14.60% over the last week, with a monthly amount drifted -8.19%, and not seem to beThis transaction had a minor impact of -0.01% on the firm's portfolio, with the shares being traded at a price of $2.03. Post-trade, T. Rowe Price Investment Management, Inc. (Trades, Portfolio ...